SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001601485-23-000052
Filing Date
2023-08-14
Accepted
2023-08-11 21:00:19
Documents
74
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q angn-20230630.htm   iXBRL 10-Q 1026228
2 EX-31.1 ex311_eltx-06302023x10xq.htm EX-31.1 11341
3 EX-31.2 ex312_eltx-06302023x10xq.htm EX-31.2 11328
4 EX-32.1 ex321eltx-06302023x10xq.htm EX-32.1 6164
5 EX-32.2 ex322_eltx-06302023x10xq.htm EX-32.2 6065
  Complete submission text file 0001601485-23-000052.txt   5952821

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT angn-20230630.xsd EX-101.SCH 50422
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT angn-20230630_cal.xml EX-101.CAL 64787
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT angn-20230630_def.xml EX-101.DEF 213977
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT angn-20230630_lab.xml EX-101.LAB 587426
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT angn-20230630_pre.xml EX-101.PRE 393702
68 EXTRACTED XBRL INSTANCE DOCUMENT angn-20230630_htm.xml XML 683699
Mailing Address 451 D STREET, 5TH FLOOR BOSTON MA 02210
Business Address 451 D STREET, 5TH FLOOR BOSTON MA 02210 (857) 209-0050
Elicio Therapeutics, Inc. (Filer) CIK: 0001601485 (see all company filings)

IRS No.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39990 | Film No.: 231165867
SIC: 2834 Pharmaceutical Preparations